Calithera Biosciences Inc
(OTCEM:CALA)
$0.0326
-0.3325[-91.07%]
Last update: 3:45PM (Delayed 15-Minutes)
Get Real Time Here
After-Hours
Open-Close-
Vol / Avg.705.000 / 1.281KMkt Cap158.843K
Day Range- - -52 Wk Range0.010 - 3.684

Calithera Biosciences Stock (OTC:CALA), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$2.67

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
20100

Analyst Firms Making Recommendations1

  • Ladenburg Thalmann
  • SVB Leerink
  • HC Wainwright & Co.
  • Wells Fargo
  • William Blair

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Calithera Biosciences

Upgrades (2)

Downgrades (5)

Initiations (1)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
11/15/2022CALABuy Now
Calithera Biosciences
$0.03Ladenburg Thalmann
Aydin Huseynov
DowngradeBuy → NeutralGet Alert
11/15/2022CALABuy Now
Calithera Biosciences
$0.036034.97%SVB Leerink
Jonathan Chang
$18 → $2DowngradeOutperform → Market PerformGet Alert
08/29/2022CALABuy Now
Calithera Biosciences
$0.0324439.88%HC Wainwright & Co.
Swayampakula Ramakanth
→ $8UpgradeNeutral → BuyGet Alert
08/16/2022CALABuy Now
Calithera Biosciences
$0.0355114.72%SVB Leerink
Jonathan Chang
$2 → $18MaintainsOutperformGet Alert
05/11/2022CALABuy Now
Calithera Biosciences
$0.036034.97%Wells Fargo
Nick Abbott
$60 → $40MaintainsEqual-WeightGet Alert
04/04/2022CALABuy Now
Calithera Biosciences
$0.036034.97%SVB Leerink
Jonathan Chang
$60 → $40MaintainsOutperformGet Alert
01/31/2022CALABuy Now
Calithera Biosciences
$0.0312169.94%Ladenburg Thalmann
Aydin Huseynov
→ $80Initiates → BuyGet Alert
01/20/2022CALABuy Now
Calithera Biosciences
$0.039102.45%SVB Leerink
Jonathan Chang
$20 → $60UpgradeMarket Perform → OutperformGet Alert
11/08/2021CALABuy Now
Calithera Biosciences
$0.03HC Wainwright & Co.
Swayampakula Ramakanth
DowngradeBuy → NeutralGet Alert
11/05/2021CALABuy Now
Calithera Biosciences
$0.03William Blair
Matt Phipps
DowngradeOutperform → Market PerformGet Alert
01/05/2021CALABuy Now
Calithera Biosciences
$0.0312169.94%HC Wainwright & Co.MaintainsBuyGet Alert
01/05/2021CALABuy Now
Calithera Biosciences
$0.036034.97%SVB Leerink
Jonathan Chang
DowngradeOutperform → Market PerformGet Alert
Q

What is the target price for Calithera Biosciences (CALA)?

A

The latest price target for Calithera Biosciences (OTCEM: CALA) was reported by Ladenburg Thalmann on November 15, 2022. The analyst firm set a price target for $0.00 expecting CALA to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Calithera Biosciences (CALA)?

A

The latest analyst rating for Calithera Biosciences (OTCEM: CALA) was provided by Ladenburg Thalmann, and Calithera Biosciences downgraded their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Calithera Biosciences (CALA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calithera Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calithera Biosciences was filed on November 15, 2022 so you should expect the next rating to be made available sometime around November 15, 2023.

Q

Is the Analyst Rating Calithera Biosciences (CALA) correct?

A

While ratings are subjective and will change, the latest Calithera Biosciences (CALA) rating was a downgraded with a price target of $0.00 to $0.00. The current price Calithera Biosciences (CALA) is trading at is $0.03, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.